Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pliant Therapeutics, Inc.

1.62
-0.0700-4.14%
Post-market: 1.630.0094+0.58%19:17 EDT
Volume:2.83M
Turnover:4.69M
Market Cap:99.20M
PE:-0.47
High:1.70
Open:1.66
Low:1.60
Close:1.69
Loading ...

Pliant Therapeutics Inc - Pauses Enrollment and Dosing in Beacon-Ipf Phase 2B Trial

THOMSON REUTERS
·
08 Feb

Pliant Therapeutics trading halted, news pending

TIPRANKS
·
08 Feb

Pliant Therapeutics Down Nearly 13%, On Track for Lowest Close Since July 2022 -- Data Talk

Dow Jones
·
08 Feb

TD Cowen Sticks to Their Buy Rating for Pliant Therapeutics (PLRX)

TIPRANKS
·
23 Jan

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
23 Jan

Pliant Therapeutics Appoints Delphine Imbert, Ph.d. as Chief Technical Officer

THOMSON REUTERS
·
22 Jan

Stock Track | Pliant Therapeutics Shares Plunge Despite Beating Q3 Earnings Estimates

Stock Track
·
09 Nov 2024

Pliant Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024

Pliant Therapeutics (PLRX) Receives a Buy from TD Cowen

TIPRANKS
·
08 Nov 2024

BRIEF-Pliant Therapeutics Q3 Net Income USD -57.763 Million Vs. IBES Estimate USD -59.3 Million

Reuters
·
08 Nov 2024

Paradigm Biocapital Advisors LP Acquires New Stake in Pliant Therapeutics Inc

GuruFocus.com
·
05 Oct 2024

Pliant Therapeutics Appoints Gary Palmer, M.d. as Senior Vice President of Medical Affairs

THOMSON REUTERS
·
02 Oct 2024

Pliant Therapeutics Inc - Grants 120,000 Stock Options to New Svp Gary Palmer

THOMSON REUTERS
·
01 Oct 2024

BRIEF-Aligos Therapeutics Strengthens Senior Leadership Team With The Appointment Of Hardean Achneck, MD As Chief Medical Officer

Reuters
·
24 Sep 2024

Aligos Therapeutics Strengthens Senior Leadership Team With the Appointment of Hardean Achneck, Md as Chief Medical Officer

THOMSON REUTERS
·
24 Sep 2024

Press Release: Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

Dow Jones
·
24 Sep 2024